Press Release

Jupiter, FL and Leland, NC (February 13, 2024) - Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences® (Nasdaq: MRVI), announced today a strategic partnership for the quantification of Host Cell Proteins (“HCP”) from the proprietary and patented C1-cells filamentous fungus Thermothelomyces heterothallica, (formerly Myceliophthora thermophila). Under the terms of the partnership...

Leland, N.C. (August 23, 2023) - Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading product and services provider for the detection and characterization of process-related impurities in biopharmaceuticals, received a 2023 R&D 100 Award from R&D World Magazine in the Analytical/Test category for the MockV® RVLP Kit.

The MockV® RVLP Kit enables bioprocess scientists to determine Retrovirus Like Particl...

SOUTHPORT, N.C. (November 7, 2022) - Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and services provider for the detection and characterization of process-related impurities in biopharmaceuticals, announced today the launch of the MockV® RVLP Kit. This kit enables bioprocess scientists to quantify the removal of Retrovirus-Like Particles (RVLPs) produced endogenously by Chinese Hamster Ovary...

SAN DIEGO (March 17, 2020) - Maravai LifeSciences, a global provider of life science reagents and services to researchers and biotech partners, announced today that it has acquired MockV Solutions. MockV plays an important role in helping biopharma customers develop manufacturing processes that are free of viral contamination, leading to the production of safe biotherapeutics. The MockV acquisition, coupled with Maravai’s previous acquisiti...

SOUTHPORT, N.C. (September 26, 2019) - Cygnus Technologies, a Maravai LifeSciences company, announced today that it has achieved ISO 9001:2015 certification. This designation certifies a high level of quality assurance and consistency and will be particularly important to Cygnus Technologies customers engaged in biotherapeutics manufacturing.

ISO is the International Organization for Standardization, and certification is a demonstration of Cygn...

MINNEAPOLIS, M.N. and SOUTHPORT, N.C. (August 12, 2019) - PRNewswire/ -- Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the ProteinSimple™-branded Ella™ immunoassay platform. Under the terms of the agreement, Bio-Techne and Cygnus are introducing the co-developed third generation CHO-HCP assay in the proprietary Simple...

SOUTHPORT, N.C. (June 24, 2019) - Cygnus Technologies, a Maravai LifeSciences company, announces an expansion of its service offerings for host cell protein (HCP) analysis. A pioneer in tools for the detection of HCP impurities in biopharmaceuticals and vaccines, Cygnus now offers services to identify and quantify those impurities, which can impact the efficacy and stability ...

SOUTHPORT, N.C. (April 18, 2019) - Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities in biopharmaceuticals, introduces the EndonucleaseGTP™ ELISA Kit for the detection and quantitation of residual endonuclease impurities in recombinant vaccines and viral vectors used for gene therapy. Endonucleases such as Benzonase* and Denarase* are oft...

SOUTHPORT, N.C. (September 6, 2017) - Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities in biopharmaceuticals, announced today that it has selected DBA Italia S.r.l. to distribute its products in Italy. DBA Italia has a 34-year track record, serving customers in biomedical research, immunology, biochemistry, molecular biology, microbiology,...

SOUTHPORT, N.C. (June 19, 2017) -  Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities in biopharmaceuticals, announced today that it has selected Bio-Connect BV to distribute the company’s products in The Netherlands, Belgium and Luxembourg.

“Bio-Connect BV is a dynamic company with excellent coverage of the life science res...

Contacts for the media

Harjit Kullar
Vice President of Marketing
Maravai LifeSciences 
Phone: (650) 697-3600 
Email: [email protected]